Emma Willems
Lawyers
Associate in our IP & Commercial Transactions practice. Previously completed a rotation in Mergers & Acquisitions.
Experience
Recent Work
- Denali Therapeutics $400 million at-the-market offering
- GSK strategic alliance with Vesalius Therapeutics
- GSK collaboration with Flagship Pioneering
- Applied Materials $700 million senior notes offering
- REGENXBIO $140 million stock and pre-funded warrants offering
- Perella Weinberg Partners $65 million follow-on offering
- Ankura Consulting Group acquisition of Lumeri
- MSCI acquisition of Trove Research
- Noile-Immune Biotech ¥3.1 billion global IPO
- Seagate HDD Cayman $1 billion senior notes offering
Education
J.D., Harvard Law School
- Executive Editor, Harvard Law Review
B.A., History, Dartmouth College
- summa cum laude
Qualifications and admissions
- State of New York